Abstract
Background
Several studies have shown the transanal total mesorectal excision (TATME) is emerging as a safe and effective technique for proctectomy. The majority of these studies to date, however, is based on procedures done in centers with teams of two surgeons working simultaneously. Few were performed by single-surgeon teams with sizeable case load. The objective of our study was to identify the feasibility and safety of a single-surgeon TATME.
Methods
Chart review of prospectively collected data on 27 patients who underwent TATME at our institution from June 2015 to September 2016 were included in this study. Indications for TATME included mid and low rectal cancers. Only patients who underwent surgery for neoplastic lesions were included in the study. Outcomes assessed included mesorectal integrity, margin status, operative time, complications, morbidity, LOS, and 30-day readmission.
Results
A total of 27 cases were available for inclusion. A single surgeon performed all procedures. The average BMI was 27.2 ± 1.3 kg/m2. The average tumor distance from anal verge was 6.8 ± 0.6 cm. The median operative time was 283 min. No intraoperative complications, including injuries and conversions, occurred. Circumferential resection margin (CRM) and distal resection margin (DRM) were R0 in 96 and 100% of patients, respectively. Mesorectal integrity was “Complete” in 67% and “Near complete” in 33% of patients. There were no incomplete specimens. The total lymph node (LN) harvest was 26 ± 2. The average LOS was 4 days for 75% of all patients. There were no mortalities. The overall morbidity was 33% (9/27). There were 4/27 anastomotic leaks, one required a laparoscopic ileostomy, one had laparoscopic drainage of an abscess, and the other two were endoscopically washed and trans-rectal drains inserted.
Conclusion
TATME performed by a one-surgeon team is oncologically adequate, and it is safe and feasible. Morbidities are comparable with existing literature data from two-surgeon teams. In addition, resection margins, mesorectal integrity, and LN harvests are also comparable or superior to some of the existing studies.
Similar content being viewed by others
References
Heald RJ. A new approach to rectal cancer. Br J Hosp Med. 1979;22(3):277–81.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.
Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, et al. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2016; doi:10.1097/SLA.0000000000001948.
Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314(13):1346–55. doi:10.1001/jama.2015.10529.
Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–63. doi:10.1001/jama.2015.12009.
Stewart DB, Dietz DW. Total mesorectal excision: what are we doing? Clin Colon Rectal Surg. 2007;20(3):190–202. doi:10.1055/s-2007-984863.
Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, Chen WS, et al. Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol. 2016;23(4):1169–76. doi:10.1245/s10434-015-4997-y.
Atallah S, Albert M, Monson JR. Critical concepts and important anatomic landmarks encountered during transanal total mesorectal excision (taTME): toward the mastery of a new operation for rectal cancer surgery. Tech Coloproctol. 2016;20(7):483–94. doi:10.1007/s10151-016-1475-x.
Ma B, Gao P, Song Y, Zhang C, Zhang C, Wang L, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer. 2016;16(1):380. doi:10.1186/s12885-016-2428-5.
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, et al., Cooperative Clinical Investigators of the Dutch Colorectal Cancer G. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol Off J Am Soc Clin Oncol. 2002;20(7):1729–34. doi:10.1200/JCO.2002.07.010.
National Cancer Institute D, Surveillance Research Program, Surveillance Systems Branch (2016) SEER Research Data 1973–2013.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89. doi:10.3322/caac.21349.
Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998;133(8):894–9.
Araujo SE, Perez RO, Seid VE, Bertoncini AB, Klajner S. Laparo-endoscopic transanal total mesorectal excision (TATME): evidence of a novel technique. Minim Invasive Ther Allied Technol MITAT Off J Soc Minim Invasive Ther. 2016:1–10. doi:10.1080/13645706.2016.1199435.
Simillis C, Hompes R, Penna M, Rasheed S, Tekkis PP. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland. 2016;18(1):19–36. doi:10.1111/codi.13151.
van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, et al., Group COcLoORIS. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8. doi:10.1016/S1470-2045(13)70016-0.
Herzog T, Belyaev O, Chromik AM, Weyhe D, Mueller CA, Munding J, et al. TME quality in rectal cancer surgery. Eur J Med Res. 2010;15:292–6.
Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, et al., Group CIS. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;372(14):1324–32. doi:10.1056/NEJMoa1414882.
Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, et al. Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg. 2015;221(2):415–23. doi:10.1016/j.jamcollsurg.2015.03.046.
Marecik SJ, Pai A, Sheikh T, Park JJ, Prasad LM. Transanal total mesorectal excision: save the nerves and urethra. Dis Colon Rectum. 2016;59(7):e410–4. doi:10.1097/DCR.0000000000000626.
Penna M, Knol JJ, Tuynman JB, Tekkis PP, Mortensen NJ, Hompes R. Four anastomotic techniques following transanal total mesorectal excision (TaTME). Tech Coloproctol. 2016;20(3):185–91. doi:10.1007/s10151-015-1414-2.
Perdawood SK, Al Khefagie GA. Transanal vs laparoscopic total mesorectal excision for rectal cancer: initial experience from Denmark. Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland. 2016;18(1):51–8. doi:10.1111/codi.13225.
Buchs NC, Wynn G, Austin R, Penna M, Findlay JM, Bloemendaal AL, et al. A two centre experience of transanal total mesorectal excision. Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland. 2016; doi:10.1111/codi.13394.
Burke JP, Martin-Perez B, Khan A, Nassif G, de Beche-Adams T, Larach SW, et al. Transanal total mesorectal excision for rectal cancer: early outcomes in 50 consecutive patients. Colorectal Dis Off J Assoc Coloproctol Great Britain Ireland. 2016;18(6):570–7. doi:10.1111/codi.13263.
Acknowledgements
We would like to thank Dr. John Snider and Dr. Ragan Reddy for their participation in patient recruitment for this project and for their advice on the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Caycedo-Marulanda, A., Jiang, H.Y. & Kohtakangas, E.L. Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer. J Gastrointest Canc 49, 455–462 (2018). https://doi.org/10.1007/s12029-017-9989-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-017-9989-7